McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
170.98
+0.98 (0.58%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 169.05 - 172.26
52 week 102.68 - 188.02
Open 169.49
Vol / Avg. 1.60M/1.36M
Mkt cap 39.35B
P/E 31.93
Div/yield 0.24/0.56
EPS 5.36
Shares 230.13M
Beta 0.79
Inst. own 86%
May 12, 2014
Q4 2014 McKesson Corporation Earnings Conference Call - 5:00PM EDT - Add to calendar
May 12, 2014
Q4 2014 McKesson Corporation Earnings Release - 4:00PM EDT - Add to calendar
Feb 25, 2014
McKesson Corporation at Citi Global Healthcare Conference
Jan 30, 2014
Q3 2014 McKesson Corporation Earnings Conference Call
Jan 30, 2014
Q3 2014 McKesson Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 0.45% 1.09%
Operating margin 1.41% 1.73%
EBITD margin - 2.37%
Return on average assets 1.73% 3.94%
Return on average equity 7.81% 19.25%
Employees 43,500 -
CDP Score - -

Address

McKesson Plaza, One Post Street
SAN FRANCISCO, CA 94104
United States - Map
+1-415-9838300 (Phone)
+1-415-9838464 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies. The Company operates in two segments: McKesson Distribution Solutions segment and McKesson Technology Solutions segment. The McKesson Distribution Solutions segment distributes drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. The McKesson Technology Solutions segment delivers enterprise clinical, patient care, financial, supply chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. In February 2013, the Company completed acquisition of Pss World Medical Inc. In February 2014, McKesson Corporation announced that its ownership in Celesio AG exceeds 75% interest.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Randall N. Spratt Chief Information Officer, Chief Technology Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Laureen E. Seeger Chief Compliance Officer, Executive Vice President, General Counsel
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 52
Bio & Compensation  - Reuters
Patrick J. Blake Executive Vice President, Group President
Age: 49
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 59
Bio & Compensation  - Reuters
Brian S. Tyler Ph.D. Executive Vice President - Corporate Strategy and Business Development
Age: 46
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 63
Bio & Compensation  - Reuters
Wayne A. Budd Independent Director
Age: 71
Bio & Compensation  - Reuters